About the Journal
Co-Editor-in-Chief : Amedeo Amedei View Profile
Abbreviated key title: J. Anal. Oncol.
ISSN (online): 1927-7229
Published by: Lifescience Global
Periodicity: 4 times per year
Months: January, April, July, October
contact us for more information
Abstracted & Indexed in: Chemical Abstracts, Open J-Gate, SCOPUS
Scope and Topics of the Journal
Analytical Oncology is a peer reviewed journal which encompasses wholly analytical aspects of the malignant disease. This comprises detections, therapy, preclinical methods, prevention, diagnosis, follow-up, and optimization and individualization of therapies.
The fundamental purpose is to deliver a unique interdisciplinary forum. Investigations connected to the etiology, diagnosis, and the treatments of cancers, as well as research from related disciplines of interest is published.
Research themes included but not limited to biomarker, pharmacogenomics, biochemistry, pharmacokinetics, drug monitoring, dose individualization, drug targeting, drug metabolism, laboratory diagnostics, other diagnostic procedures, tumour and microbiology.
Indexed and Abstracted in
The journal is addressed to both practicing professionals and researchers in the field of oncology, professionals in academia, former researchers and PhD students and other specialists interested in the results of scientific cancer research.
Peer Review Policy
All journals published by Lifescience Global follow the peer review system designed for each article published.
- Manuscript topics are normally approved by senior editors followed by formal peer review conducted in collaboration with editorial board members and independent referees appointed by editorial team of each journal.
- In case of theme issue on a particular topic, the appointed Guest Editor is responsible to conduct peer review and submit full review reports along with accepted manuscripts of the journal.
- Lifescience Global encourages its editorial teams to use the electronic submission and peer-review system for its journals to facilitate them during peer review process.
Publication Ethics and Publication Malpractice Statement
Lifescience Global allows FEE Waiver to authors from any of the below countries which were classified by the World Bank as Low-income economies or Lower-middle-income economies as of September 2012 (reference - World Bank 1st September 2012).
List of Countries: